Kenneth J. Widder
Independent DirectorDr. Kenneth J. Widder, also known as Ken, M.D. is a Venture Consultant at Latterell Venture Partners. Previously, he was a General Partner at the firm since 2007. Dr. Widder serves as an Independent Director at Personalis, Inc. since June 2023. Dr. Widder was a General Partner at Windamere Venture Partners. Prior to this, he founded and served as the Chief Executive officer of NovaCardia. He founded and served as the Chief Executive Officer of Santarus, Inc. and served as its Chairman from March 2000 to February 2004. He served as the Chief Executive Officer and Chairman of Converge Medical. He started his career as the Founder, Chairman and Chief Executive Officer of Molecular Biosystems, where Dr. Widder was responsible for the development and approval of AlbunexTM and Optison TM. Simultaneously, he held the position of the Chairman and Chief Executive Officer of Syngene, Inc. from 1990 to 1993. He served as Independent Director of Evoke Pharma, Inc., since June 2007 until December 15, 2025. He is an Independent Director of Sirion Holdings, Inc., since October 21, 2006 and QuidelOrtho Corporation (formerly known as Quidel Corporation) since November 18, 2014. He serves on the Board of Tokalas, Inc., Alastin Skincare, Inc., Kalyra Pharmaceuticals Aptinyx Inc., Vision of Children, San Diego Museum of Art, Meritage Pharma, Inc. and San Diego BIOCOM and is a Trustee of Carleton College. He is a Director of Naurex, Inc. since May 11, 2011. Dr. Widder was appointed as the Chairman of both the San Diego Regional Technology Alliance and San Diego Technology Council. He was a General Partner with LVP Life Science Ventures, a venture capital company for biotechnology and medical device start-ups, from 2007 to 2016. He served as a Director of Luminous Medical, Inc. He served as Director of Converge Medical, Inc. and FeRx, Inc. He served as a Director of eStudySite, Inc. Dr. Widder previously served on the Boards of Titan Pharmaceuticals, Inc., DigiVision, Inc., Wilshire Technologies, Inc. and The California Healthcare Institute, as well as the UCSD Cancer Center Foundation. Dr. Widder serves on the boards of Sydnexis, Inc. Dr. Widder has founded seven companies and was Chairman and Chief Executive Officer of five of these companies. His last company, Sytera Inc., merged with Sirion Therapeutics, an ophthalmology specialty pharmaceutical company. Dr. Widder was Founder of Converge Medical, Inc. He is author and co-author of over 25 scientific publications and is the owner and inventor of over 30 patents and patent applications. He was Chairman and CEO of Sydnexis, Inc., an ophthalmology start-up company, since 2017 until 2022. He served as Executive Chairman of OrphoMed, Inc from 2017 to 2022. He has experience working with biomedical companies since 2017. He holds an M.D. degree from Northwestern University and a BA in biology from Carleton College. Dr. Widder trained in pathology at Duke University Medical Center.
Positions
- Company NameQuidelOrtho CorporationStock CodeQDELPositionIndependent DirectorColleagues
- BJBrian J. BlaserPresident, CEO & Director
- KFKenneth F. BuechlerIndependent Non-Executive Chairman
- PDPhilip D. McLellanChief Operations Officer
- JPJonathan P. SiegristHead of Point of Care Diagnostics
- MYMicah YoungChief Financial Officer & Principal Financial Officer
- SSSanjeev SharmaVice President of Investor Relations
- ELEdward L. MichaelIndependent Director
- ADAnn D. RhoadsIndependent Director
